|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:1176-1182
© 2002 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease (CHD) |
From the Division of Pediatric Cardiology,a the Division of Cardiovascular Diseases and Internal Medicine,b the Division of Cardiovascular Surgery,c the Department of Anesthesiology,d and the Section of Biostatistics,e Mayo Clinic, Rochester, Minn.
Supported in part by an internal grant from the Mayo Foundation.
Received for publication Sept 9, 2001. Revisions requested Sept 11, 2001; revisions received April 11, 2002. Accepted for publication April 18, 2002. Address for reprints: Patrick W. O'Leary, MD, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (E-mail: poleary{at}mayo.edu).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The largest experience specifically evaluating the utility of intraoperative echocardiography, involving more than 1000 cases, was published by Ungerleider and associates.
12 Their study evaluated both epicardial and transesophageal echocardiography. Disadvantages of epicardial imaging include invasion of the surgical field, limited windows, possible induction of ventricular ectopic beats, and possible transient hypotension.
9 ITEE has therefore become the preferred modality of imaging during surgery for congenital heart defects.
Arguments pertaining to the use of ITEE focus on the cost and the risk of complications related to the procedure versus the benefit to the patient.
13 Ungerleider and associates
12 reported, "The average cost for patients who return to the operating room during their hospitalization for revision of a repair is significantly greater than for those whose repairs are revised before they leave the operating room ($94,180.28 ± $33,881.63 versus $21,415.79 ± $8215.74)." Subsequent cost analysis by Stevenson
14 from Seattle focused on a series of ITEE use in which a 2.8% rate of immediate surgical revision was found to be cost-effective.
As a continuation of the previous Mayo experience with ITEE, we are reporting this series involving only biplanar or multiplanar ITEE during surgical repair for congenital heart defects. This was a collaborative study involving pediatric cardiovascular surgeons, congenital cardiologists, and anesthesiologists. The first objective of this study was to better define the impact of ITEE in a larger group of patients. The second objective was to determine specifically the appropriate indications for ITEE during surgery for congenital heart defects.
| Methods |
|---|
|
|
|---|
Study design
Biplanar or multiplanar ITEE was performed and interpreted by a cardiologist at the request of the surgeon for most intracardiac procedures. Epicardial echocardiograms were excluded from this study. ITEE was not routinely performed for simple extracardiac procedures such as pulmonary artery banding, systemic-pulmonary arterial shunts, or isolated coarctation repairs. All ITEE procedures were performed with commercially available echocardiographic systems (Hewlett Packard Sonos 1000-2500; Hewlett-Packard Company, Palo Alto, Calif; or Acuson XP-10; Acuson Corporation, Mountain View, Calif). All ITEE probes had either biplanar or multiplanar capability. Pediatric probes with a tip diameter of 10 mm were usually used in patients weighing less than 15 kg. Adult ITEE probes with a tip diameter of 12 to 13 mm were used in patients weighing more than 15 kg.
Impact was defined by the cardiologist and surgeon at the time of the procedure and was described as one of five distinct impact categories. The four positive impact categories were prebypass major impact, prebypass minor impact, postbypass major impact, and postbypass minor impact. If no new information was revealed on either the prebypass or the postbypass scan, the fifth category, no impact, was recorded for that patient.
The first major impact category was defined as unique prebypass information obtained by ITEE that altered the planned surgical procedure. An example would be the identification of an atrial septal defect (ASD) not previously known to be present in a patient undergoing a reoperation in which atrial exposure was not planned (for example, a right ventricle-pulmonary artery conduit replacement). The second major impact category was defined as unique postbypass information that described clinically significant residual findings that would not have been found by routine surgical pressure measurements. To be considered major impact, these findings required a return to bypass for surgical revision of the initial repair. An example would be an iatrogenic ventricular septal defect (VSD) after subaortic resection that required bypass again for surgical closure. Combined major impact rates refer to the percentage of patients in a group who had either prebypass or postbypass major impact. If a patient had impact in both categories during a single surgical procedure, that patient was counted only once in the calculation of the combined impact rate.
The first of two minor impact categories was described as new prebypass information that did not alter the surgical plan but did refine the diagnosis. An example would be a previously undetected ASD in a patient with Ebstein anomaly that would have been visualized by the surgeon during routine inspection of the atrium before tricuspid valve repair and thus did not change the surgery. The second minor impact category was new postbypass information that did not lead to surgical intervention. An example would be moderate mitral valve regurgitation after attempted valve repair in which this result was accepted and not revised.
Statistical methods
Statistical analysis was performed for each of five categories: (1) prebypass major impact, (2) postbypass major impact, (3) combined prebypass and postbypass major impact, (4) prebypass minor impact, and (5) postbypass minor impact. The four parameters used for analysis within each category were age, surgical history (first operation vs reoperation), primary diagnosis, and surgical procedure performed. In analyzing surgical history, only the first operation performed during the study period was included. Statistical analysis included the use of logistic regression models in establishing associations between echocardiographic benefits and patient characteristics. Generalized estimating equations were used within these logistic regression models.
15 This made it possible to use data from patients who had more than one operation by accounting for within-patient correlations. It was computationally impossible to evaluate two of the variables of interestdiagnosis and surgical planwith generalized estimating equations because of the large number of diagnostic and surgical categories and the sparseness of observations in several of the categories. For these variables, the significance of their association with the benefit questions was assessed with the Fisher exact test.
Cost analysis
Cost analysis was performed by comparing the 1999 charges for the 1002 ITEEs with the cost saving of avoiding late reoperations in the postbypass major impact cases. No attempt was made to assign a monetary value to the prebypass information supplied by ITEE. Four of the 56 patients required bypass again because of regional wall motion abnormalities caused by air in the coronary arteries. Ventricular function for these patients improved after this second bypass without surgical revision. Because no additional surgery was performed, these 4 patients were excluded from the total reoperation cost analysis.
Total estimated hospital charges for reoperation in the patients with postbypass major impact were calculated with the assumption that the reoperation occurred during the same hospitalization as the initial surgery. All monetary figures were based on 1999 charges. According to the surgical indication for revision of the initial operation, a surgical base charge was established for each patient. The total time in the operating room for the hypothetic late reoperation was assumed to be 4 hours (to calculate the incremental operating room charges). The charge for cardiovascular anesthesia with standard supplies was based on the average cost for 20 patients with similar diagnoses.
Each patient undergoing late reoperation was assumed to require 3 additional days in the intensive care unit. A charge for one transthoracic echocardiogram was added to the operating room and intensive care charges to derive the total estimated cost for a late reoperation. Charges for consulting medical services, laboratory and radiology tests, and additional days in the hospital but not in the intensive care unit were not included in the cost analysis because of the high variability for each individual patient.
Our analysis compared the total estimated cost of late reoperation in the 52 patients with postbypass major impact with 1999 charges for 1002 ITEE studies in patients with congenital heart defects. The cost for the ITEE included the equipment charge, prebypass and postbypass pediatric cardiology interpretation, and the charge for probe insertion.
| Results |
|---|
|
|
|---|
Major impact
The combined major impact rate for the series was 13.8% (n = 138/1002). Separate rates of preoperative and postoperative major impact were 9.1% (n = 91/1002) and 5.6% (n = 56/1002), respectively. Findings associated with major impact are summarized in Tables 1 and 2.
|
|
|
Forty-six percent of patients had no previous history of cardiac surgery and 54% had a history of at least one previous intracardiac or extracardiac operation. Table 2
describes the rates of major impact observed according to surgical history. Patients with previous cardiac surgery had a higher incidence of combined major impact than did those patients with no previous surgery (16.1% vs 11.3%, P = .028). According to generalized estimating equations logistic regression models, the odds of having major impact from either the prebypass or the postbypass scan in the combined category were 1.52 times higher for patients with previous surgery than for those undergoing their first cardiac procedure. Patients with previous cardiac surgery also had a greater incidence of prebypass major impact (10.9% vs 6.7%, P = .026). Rates of postbypass major impact were similar in the two groups (Table 4).
|
|
|
|
|
Minor impact
Overall, the minor impact rate for the pre-bypass ITEE was 12.3% (n = 123/1002) and that for the postbypass ITEE was 10% (n = 100/1002). A slightly higher prebypass minor impact rate was observed in the reoperation group (13.7% vs 10.6%). However, neither age nor operative status was statistically significant as a predictor of minor impact.
Complications
Complications were reported by the cardiologist, surgeon, and anesthesiologist. No major complications, defined as death, esophageal or gastric perforations, accidental extubations, upper gastrointestinal bleeding, or endocarditis, occurred as a result of ITEE during the study period. Minor complications, defined as transient airway compression, problems with ventilation, or compression of the descending aorta by the probe, were observed in 10 patients, or 1% of the study population. Minor complications were most common in patients weighing less than 4 kg. ITEE was performed in 51 patients weighing less than 4 kg. Minor complications occurred in 6 of these infants, representing a minor complication rate of 11.8% in this subset of patients.
Cost analysis
Fifty-two patients had revision of their initial surgical repair before leaving the operating room on the basis of ITEE findings. The total estimated cost for these 52 late reoperations (performed at a later time during the same hospital stay) would have been $895,664, or $15,994 per operation. Reoperation costs included charges for the procedure performed, incremental operating room fees, anesthesia and supplies, 3 nights in the intensive care unit, and one transthoracic echocardiogram. The total 1999 charges for 1002 ITEE studies would have been $746,490, or $745 per ITEE. Thus this model predicts that ITEE produced an overall saving of $149,174 by avoiding the costs of late reoperation in this patient group. These data suggest that if ITEE prompted an immediate surgical revision in 5% of patients studied, the ITEE service would pay for itself, even without considering any benefits derived from the preoperative scan.
| Discussion |
|---|
|
|
|---|
Although relatively low impact rates were observed for some diagnostic categories (partial anomalous pulmonary venous connection, tricuspid valve repair other than for Ebstein anomaly, simple atrioventricular discordance, aortic arch anomalies, and secundum ASDs), instances of major impact did occur among these patients. One could reasonably ask whether the routine use of ITEE is truly indicated for these low-impact categories. In our study population, no major complications occurred. Only 1% of patients had minor complications, which occurred primarily in neonates weighing less than 4 kg. As technology continues to advance, the introduction of smaller ITEE probes should minimize such minor complications in the future. Previous studies also support the conclusion that ITEE in pediatric and adult patients is a safe procedure.
16-18 Therefore the low risk of complications does not detract from considering routine use of ITEE.
If adequate medical resources are available, then the final question involves the cost-benefit profile of routine use of ITEE for all patients with congenital heart defects. Stevenson
14 reported a series of operations with ITEE in which a 2.8% rate of immediate surgical revision was found to be cost-effective. The total cost for reoperation in 11 patients was $418,447, or $38,040 per operation. The total cost of performing 400 ITEEs was $259,670, or $650 per ITEE. Thus in this particular patient group the overall savings were $158,777.
14 One may therefore extrapolate from these data that the break-even point is a postbypass major impact rate of 1.8% (n = 7/400). The cost analysis performed for our patient population also supports the conclusion that ITEE is cost-effective. We found an immediate revision rate of 5% to be cost-effective for routine application of ITEE. The major difference in cost analysis between the two studies was the charge for reoperation ($38,040 for Stevenson
14 versus $15,994 in our study). Our cost analysis was based on a minimalist strategy and included only essential charges for the reoperation. Miscellaneous charges for consulting medical services, laboratory and radiologic tests, and additional days in the hospital on the ward were not included in the cost analysis because of the high variability for each individual patient.
Although the exact costs of reoperation can be debated, the data still indicate that routine use of ITEE during surgery for congenital heart defects is cost-effective. It is important to note that this conclusion is based only on postoperative major impact. There are clearly additional benefits derived from ITEE, including new information acquired on the preoperative scans that may lead to changes in the planned surgery. The preoperative benefits of ITEE are difficult to quantitate. Preoperative impact would certainly be reduced if all or most patients had transesophageal echocardiography as part of their outpatient evaluation. We believe that this approach is usually unnecessary. Instead, we have reserved outpatient transesophageal echocardiographic evaluation for those situations in which there is a question of whether to proceed to surgery. When a patient clearly needs an operation on the basis of routine evaluations, we prefer to perform ITEE in the operating room. This is true even if there are some questions that have not been completely addressed by the preceding evaluation. ITEE allows both the cardiologist and the surgeon to be present during the evaluation and to review the data together before formulating a final surgical plan. We recognize that this preference has probably influenced the frequency with which ITEE was found to have major preoperative impact in our series. However, we believe that this approach is the most efficient method, particularly for pediatric patients, who would generally require an additional general anesthetic if transesophageal echocardiography were performed outside the operating room.
Limitations of the study
Because of the referral pattern at the Mayo Clinic, our study population has a larger proportion of adults with congenital heart defects than most previous reports. In addition, ITEE was not performed during all neonatal intracardiac procedures. For example, repair of total anomalous pulmonary venous connections frequently was not evaluated with ITEE because the probe would possibly compromise surgical exposure in the posterior mediastinum. Also, in some cases ITEE was not requested if the weight of the neonate was so low that ventilation problems could occur. Therefore our conclusions may not be easily generalized to a broad neonatal population. However, they should apply to the vast majority of patients requiring repair of congenital heart defects, namely those weighing more than 4 kg.
Conclusions
Major impact was observed in almost all diagnostic and surgical categories and was more common among patients who had previous cardiac surgery. There were no major complications, and minor complications were rare. Even though some diagnostic and surgical groups had relatively low rates of major impact, observed overall frequencies of major impact and immediate revision support the premise that routine use of ITEE would be cost-effective. We therefore believe that routine use of ITEE during intracardiac surgery for all congenital heart defects is justified.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 2, 2008; 52(23): e1 - e121. [Full Text] [PDF] |
||||
![]() |
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1890 - 1947. [Full Text] [PDF] |
||||
![]() |
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, December 2, 2008; 118(23): e714 - e833. [Full Text] [PDF] |
||||
![]() |
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, December 2, 2008; 118(23): 2395 - 2451. [Full Text] [PDF] |
||||
![]() |
O. Honjo, Y. Kotani, S. Osaki, Y. Fujita, T. Suezawa, A. Tateishi, K. Ishino, M. Kawada, T. Akagi, and S. Sano Discrepancy Between Intraoperative Transesophageal Echocardiography and Postoperative Transthoracic Echocardiography in Assessing Congenital Valve Surgery Ann. Thorac. Surg., December 1, 2006; 82(6): 2240 - 2246. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Russell, K. Rouine-Rapp, G. Stratmann, and W. C. Miller-Hance Congenital heart disease in the adult: a review with internet-accessible transesophageal echocardiographic images. Anesth. Analg., March 1, 2006; 102(3): 694 - 723. [Full Text] [PDF] |
||||
![]() |
P. P Sengupta and B. K Khandheria Transoesophageal echocardiography Heart, April 1, 2005; 91(4): 541 - 547. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |